McLaughlin Tracey, Allison Gregory, Abbasi Fahim, Lamendola Cindy, Reaven Gerald
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Metabolism. 2004 Apr;53(4):495-9. doi: 10.1016/j.metabol.2003.10.032.
Obese individuals tend to be both insulin resistant and at increased risk to develop cardiovascular disease (CVD). Given the increased prevalence of obesity in the US population, we thought it important to define the relationship between degree of obesity and insulin-mediated glucose disposal in the population at large, as well as the relationship between obesity, insulin resistance, and CVD risk in these individuals. To do this we quantified insulin-mediated glucose disposal in 465 healthy volunteers by determining the steady-state plasma glucose (SSPG) concentrations at the end of a 180-minute infusion of somatostatin, insulin, and glucose. Adiposity was estimated by body mass index (BMI) and the relationship between BMI and SSPG defined. In addition, a series of CVD risk factors were measured, including blood pressure, plasma glucose, and insulin concentrations, before and after 75 g of oral glucose, and fasting plasma lipid and lipoprotein concentrations. The results indicated that SSPG concentration and BMI were significantly correlated (r = 0.54, P >.001), and 36% of individuals in the most insulin-resistant tertile were obese (BMI >/= 30.0 kg/m(2)). However, 16% of those in the most insulin-resistant tertile were of normal weight (BMI < 25.0 kg/m(2)). Although CVD risk factors were accentuated in general with progressive increases in either BMI or SSPG concentration, important differences were noted. Thus, the higher the SSPG concentration, the more the increase in plasma glucose, insulin, and triglyceride (TG) concentrations, whereas the greater the BMI, the higher the low-density lipoprotein concentration. Furthermore, while CVD risk factors increased significantly with each tertile of insulin resistance, significant differences in CVD risk were only apparent when the lowest BMI tertile was compared with the other 2, with the values in the middle and upper BMI differing from each other. These results show that while BMI and insulin resistance are related, they are not synonymous, and that they make independent and different contributions to increasing CVD risk.
肥胖个体往往既存在胰岛素抵抗,又有患心血管疾病(CVD)的风险增加。鉴于美国人群中肥胖患病率的上升,我们认为确定肥胖程度与一般人群中胰岛素介导的葡萄糖处置之间的关系,以及这些个体中肥胖、胰岛素抵抗和CVD风险之间的关系很重要。为此,我们通过在输注生长抑素、胰岛素和葡萄糖180分钟结束时测定稳态血浆葡萄糖(SSPG)浓度,对465名健康志愿者的胰岛素介导的葡萄糖处置进行了量化。通过体重指数(BMI)估计肥胖程度,并确定BMI与SSPG之间的关系。此外,在口服75克葡萄糖前后,测量了一系列CVD危险因素,包括血压、血浆葡萄糖和胰岛素浓度,以及空腹血浆脂质和脂蛋白浓度。结果表明,SSPG浓度与BMI显著相关(r = 0.54,P >.001),在胰岛素抵抗最严重的三分位数中,36%的个体肥胖(BMI≥30.0 kg/m²)。然而,在胰岛素抵抗最严重的三分位数中,16%的个体体重正常(BMI < 25.0 kg/m²)。尽管随着BMI或SSPG浓度的逐渐升高,CVD危险因素总体上会加剧,但仍存在重要差异。因此,SSPG浓度越高,血浆葡萄糖、胰岛素和甘油三酯(TG)浓度的升高就越明显,而BMI越高,低密度脂蛋白浓度就越高。此外,虽然随着胰岛素抵抗的每个三分位数,CVD危险因素显著增加,但只有当最低BMI三分位数与其他两个三分位数进行比较时,CVD风险的显著差异才明显,中间和较高BMI值之间彼此不同。这些结果表明,虽然BMI与胰岛素抵抗相关,但它们不是同义词,并且它们对增加CVD风险有独立且不同的贡献。